Key result
Intracoronary placement of the Carbostent followed by aspirin monotherapy resulted in 0% stent thrombosis or major adverse cardiac events at 1-month follow-up.
Why the study?
Does Carbostent implantation followed by aspirin monotherapy prevent early stent thrombosis in selected patients undergoing coronary revascularization?
Observational (n=110)
Does Carbostent implantation followed by aspirin monotherapy prevent early stent thrombosis in selected patients undergoing coronary revascularization?
No takes yet. Share an insight, caveat, or question.
In selected patients, implantation of the Carbostent followed by aspirin monotherapy appears safe and may prevent early stent thrombosis without the need for dual antiplatelet therapy.
Bartorelli et al. (2002) conducted an observational in Coronary artery disease requiring revascularization (n=110). Carbostent implantation with aspirin monotherapy was evaluated on Stent thrombosis or other major adverse cardiac events. Intracoronary placement of the Carbostent followed by aspirin monotherapy resulted in 0% stent thrombosis or major adverse cardiac events at 1-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: